Max Eldon Jones Dpm is categorized under Internal Medicine Practitioners in Salt Lake City, UT and active since 2000.
Max Eldon Jones Dpm was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact David Seegmiller at the company’s single location by writing to 508 East South Temple # 118, Salt Lake City, Utah UT 84102 or by phoning (801) 285-7060. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Max Eldon Jones Dpm |
Contact Person: | David Seegmiller |
Address: | 508 East South Temple # 118, Salt Lake City, Utah 84102 |
Phone Number: | (801) 285-7060 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2000 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Max Eldon Jones Dpm was started in 2000 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Seegmiller for inquiries that concern Max Eldon Jones Dpm by calling the company number (801) 285-7060, as your correspondence is most welcome. Additionally, the physical location of the single location of Max Eldon Jones Dpm can be found at the coordinates 40.769212,-111.87643 as well as the street address 508 East South Temple # 118 in Salt Lake City, Utah 84102.
For its online presence, you may visit Max Eldon Jones Dpm’s website at and engage with its social media outlets through on Twitter and on Facebook.